The stereoselective biotransformation of the anti-obesity drug sibutramine in rat liver microsomes and in primary cultures of rat hepatocytes

Abstract

Sibutramine is an anti-obesity drug sold as racemic mixture. Lower biotransformation of R-sibutramine, together with its higher effectiveness in depressing food intake and decreasing body weight make this enantiomer more advantageous